Gene · 7832
Papers2,269
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,269
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| miR-17-92 cluster-BTG2 axis regulates B-cell receptor signaling in mantle cell lymphoma. | Cancer Sci | 2024 | 38050664 | PubTator, text mining | PubMed |
| m6A-related lncRNAs as potential biomarkers and the lncRNA ELFN1-AS1/miR-182-5p/BCL-2 regulatory axis in diffuse large B-cell lymphoma. | J Cell Mol Med | 2024 | 38037859 | PubTator, text mining | PubMed |
| Regulation of long non-coding RNA expression by aryl hydrocarbon receptor activation. | Toxicol Lett | 2024 | 38036013 | PubTator, text mining | PubMed |
| Transcriptome analysis of the cerebral cortex of acrylamide-exposed wild-type and IL-1β-knockout mice. | Arch Toxicol | 2024 | 37971544 | PubTator, text mining | PubMed |
| Differential expression of TOB/BTG family members in patients with plaque psoriasis: cross-sectional study. | Immunol Res | 2024 | 37874431 | PubTator, text mining | PubMed |
| A pipeline to characterize p53 effectors by integrative cistrome and transcriptome analysis in a genetically-defined organoid model. | Genes Dis | 2024 | 37692486 | PubTator, text mining | PubMed |
| Transcriptional regulation in the development and dysfunction of neocortical projection neurons. | Neural Regen Res | 2024 | 37488873 | PubTator, text mining | PubMed |
| Unraveling Roles of miR-27b-3p as a Potential Biomarker for Breast Cancer in Malay Women via Bioinformatics Analysis. | Int J Mol Cell Med | 2023 | 38751652 | PubTator, text mining | PubMed |
| Establishment of a pathomic-based machine learning model to predict CD276 (B7-H3) expression in colon cancer. | Front Oncol | 2023 | 38260829 | PubTator, text mining | PubMed |
| Pathogenesis, clinical features, and treatment of plurihormonal pituitary adenoma. | Front Neurosci | 2023 | 38260014 | PubTator, text mining | PubMed |
| Concurrent remission of lymphoma and Sjögren's disease following anti-CD19 chimeric antigen receptor-T cell therapy for diffuse large B-cell lymphoma: a case report. | Front Immunol | 2023 | 38173731 | PubTator, text mining | PubMed |
| DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic Leukemia: Focus on the Genes Involved. | Int J Mol Sci | 2023 | 38139431 | PubTator, text mining | PubMed |
| Single-cell characterization of human GBM reveals regional differences in tumor-infiltrating leukocyte activation. | Elife | 2023 | 38127790 | PubTator, text mining | PubMed |
| Immune and oxidative stress disorder in ovulation-dysfunction women revealed by single-cell transcriptome. | Front Immunol | 2023 | 38116006 | PubTator, text mining | PubMed |
| Non-coding RNA methylation modifications in hepatocellular carcinoma: interactions and potential implications. | Cell Commun Signal | 2023 | 38111040 | PubTator, text mining | PubMed |
| The involvement of E3 ubiquitin ligases in the development and progression of colorectal cancer. | Cell Death Discov | 2023 | 38104139 | PubTator, text mining | PubMed |
| HER2 low expression breast cancer subtyping and their correlation with prognosis and immune landscape based on the histone modification related genes. | Sci Rep | 2023 | 38066224 | PubTator, text mining | PubMed |
| A pan-cancer analysis of anti-proliferative protein family genes for therapeutic targets in cancer. | Sci Rep | 2023 | 38062199 | PubTator, text mining | PubMed |
[Analysis of the feasibility and prognostic value of circulating tumor DNA monitoring in detecting gene mutations in patients with diffuse large B-cell lymphoma receiving chimeric antigen receptor T-cell therapy]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 38049331 | PubTator, text mining | PubMed |
| Identification of differentially expressed genes associated with the pathogenesis of gastric cancer by bioinformatics analysis. | BMC Med Genomics | 2023 | 38041130 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7832/papers?page=8